Qube Research & Technologies (QRT)
MAZE

Qube Research & Technologies (QRT)’s Maze Therapeutics MAZE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91M Sell
131,043
-3,907
-3% -$102K ﹤0.01% 1758
2026
Q1 		$4.03M Buy
+134,950
New +$5.96M ﹤0.01% 1779

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MAZE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Maze Therapeutics (MAZE) stake by 2.9% in Q2 2026, selling an estimated $102K and leaving 131,043 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

Qube Research & Technologies (QRT) first reported a position in MAZE in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.03M in Q1 2026. 162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 131,043 shares of Maze Therapeutics worth $3.91M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 3,907 Maze Therapeutics shares in Q2 2026, an estimated $102K.
  • Maze Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1758 holding.
  • Qube Research & Technologies (QRT) first reported a position in Maze Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Qube Research & Technologies (QRT)'s Maze Therapeutics position peaked at $4.03M in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.